Stay in touch
Prime news from our network.
#read
SPRIND agency for skydiving innovations wins 290,000 US dollars
The Federal Agency for Breakthrough Innovations (SPRIND), in collaboration with economists from the University of Chicago, has presented a new financing model to promote the development of broad-spectrum antiviral drugs to improve pandemic preparedness. The aim of the initiative is to provide manufacturers with financial security for the development and production of new active substances through an international Advance Market Commitment (AMC).
10/09/2024
According to new research results from SPRIND, the early availability of such drugs could prevent losses totalling 28.2 trillion US dollars and save millions of lives in the event of a future pandemic. The initiative is based on lessons learnt from the COVID-19 pandemic, where the late availability of therapeutics such as paxlovid hampered the fight against the disease. SPRIND is working closely with the University of Chicago's Market Shaping Accelerator (MSA) to develop innovative financing mechanisms that make investments in pandemic preparedness more attractive.
The supporting experts include Nobel Prize winner Michael Kremer and other renowned scientists who emphasise that robust and rapidly available antiviral drugs are crucial for containing future pandemics. The initiative is also supported by international health authorities such as the WHO and other organisations that emphasise the need for new therapeutics to protect global health.
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.